 |
|
Characteristics of Toxic Epidermal Necrolysis in Patients Undergoing Long-term Glucocorticoid Therapy
Fabien Guibal, MD;
Sylvie Bastuji-Garin, MD;
Olivier Chosidow, MD;
Philippe Saiag, MD;
Jean Revuz, MD;
Jean-Claude Roujeau, MD
Arch Dermatol. 1995;131(6):669-672.
Abstract
| |
Background and Design
The usefulness of steroid therapy in toxic epidermal necrolysis (TEN) remains controversial. Up to 5% of the TEN cases occur in patients who undergo long-term steroid therapy. We, thus, looked for the potential effect of long-term glucocorticosteroid therapy before the onset of TEN on altering the progression of the disease. The records of 179 patients were reviewed. The characteristics of the 13 patients who were undergoing long-term glucocorticosteroid therapy were compared with those of 166 other patients with TEN. The following parameters were studied: age, mortality, delay between the introduction of the suspect drug and the onset of TEN, length of hospital stay, body surface area involved, time elapsed between the first symptom of TEN and hospital admission, number of medications taken by the patients before the onset of TEN, lymphocyte count, granulocyte count, platelet count, glycemia, serum aspartate aminotransferase level, and total disease duration.
Results
Patients who were undergoing long-term glucocorticosteroid therapy differed from other patients with TEN in the administration of more drugs, longer delay between the introduction of the suspect drug and the onset of TEN, and a longer time elapsed between the first symptom of TEN and hospital admission. We observed no differences for the other parameters that were studied.
Conclusion
Our study shows that long-term steroid therapy may delay the onset of TEN, but it does not hall its progression.
(Arch Dermatol. 1995;131:669-672)
Author Affiliations
From the Dermatologic Intensive Care Unit, Department of Dermatology, Hôpital Henri Mondor, Université Paris XII, Créteil, France. Currently, Dr Chosidow is with the Unité de Dermatologie, Hôpital Pitié-Salpêtrière, Paris, and Dr Saiag is with the Service de Dermatologie, Hôpital Ambroise Paré, Boulogne, France. Dr Guibal was a dermatology resident at the time this work was done.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Management of toxic epidermal necrolysis and related syndromes
Mukasa and Craven
Postgrad. Med. J. 2008;84:60-65.
ABSTRACT
| FULL TEXT
Stevens-Johnson Syndrome Secondary to Vancomycin Exposure
Boosinger and Thomas
Journal of Pharmacy Practice 2002;15:515-518.
ABSTRACT
Corticosteroids for TEN?
Journal Watch Dermatology 1995;1995:11-11.
FULL TEXT
Erythema Multiforme: Should Anyone Care About the Standards of Care?
Rasmussen
Arch Dermatol 1995;131:726-729.
ABSTRACT
|
